To assess the safety and efficacy in routine clinical practice of balloon dilatation procedures in the treatment of paediatric airway stenosis.
| INTRODUC TI ON
Stenosis (narrowing) of the airway encompasses a range of potentially life-threatening conditions that may be congenital or caused by prolonged or repeated airway intubation. Children with airway stenosis often experience difficulties with breathing, speaking or eating. 1 Such symptoms may require further intubation, leading to a cyclical problem.
Surgical interventions for airway stenosis include cricoid split procedures, reconstructive laryngotracheal procedures and more commonly, tracheostomy. Endoscopic balloons offer a potential alternative or adjunct to open surgery. 2 In 2012, the National Institute for Health and Care Excellence (NICE) published Interventional Procedures Guidance which identified that safety and efficacy evidence for endoscopic balloon dilatation for subglottic or tracheal stenosis was lacking in quantity and quality. 3 The guidance recommended that clinicians wishing to conduct the procedure should do so under special arrangements for clinical governance, audit and consent, including national data collection.
In response to this NICE guidance, the Airway Intervention Registry (AIR) was developed, enabling UK data collection for ENT/ respiratory procedures conducted on children. 4 This study reports results from the AIR, to determine whether balloon dilatation procedures in the treatment of paediatric airway stenosis are effective and safe, in a National Health Service (NHS) setting. The AIR records the following: clinical history, patient questionnaires, medical assessments, procedural details, post-procedure, discharge and hospital resource usage information (Supplementary Material 1). Data were extracted from the AIR for analysis on 3 October 2019.
| MATERIAL S AND ME THODS

| Ethical considerations
| Data source
| Study population
| Inclusion criteria
Patients <18 years old with airway stenosis treated by balloon dilatation within an acute NHS hospital.
| Exclusion criteria
Procedures conducted for indications other than airway stenosis and records with no balloon dilatation procedure data.
| Data cleaning
Balloon procedures were numbered consecutively for each patient based on the hospital procedure date. Interim analyses and data quality checks were conducted bi-monthly. 
| Data coverage
| In-hospital outcome measures
Efficacy outcome measures were as follows: intra-operative change in airway diameter (millimetres) and Cotton-Myer grade directly before and after the balloon dilatation intervention.
Cotton-Myer grade was calculated using the measured airway Keypoints • A total of 133 balloon procedures conducted during 128 hospital visits in 59 paediatric patients with airway stenosis were recorded in the Airway Intervention Registry.
• 88% of visits were for the sole and primary treatment for stenosis, 50% with a tracheostomy in place.
• Balloon dilatation was associated with increase in airway diameter over time, but this was not compared with increases due to natural growth. diameter compared with an age-related healthy cricoid anteroposterior diameter. 6 In the absence of a measured airway diameter, Cotton-Myer grade was estimated by the treating clinician.
Safety outcome measures included in-hospital complications
and in-hospital death. All reported complications were clinically reviewed and aggregated into an in-hospital complication rate.
Secondary outcome measures were hospital resource usage, discharge to planned location and length of stay.
| Longer-term outcome measures
The AIR and HES were pseudonymously linked on treating hospital, patient gender, age, procedure, admission and discharge dates to 
| Statistical analysis
All scripts for applying eligibility criteria, data cleaning, processing and statistical analysis were written in the statistical programming language R. 9 Patient characteristics, clinical history and complications were summarised using descriptive statistics. Repeated-measures models (taking into account the random effect of some patients having multiple balloon procedures over time) were used to test for intra-operative changes in airway diameter with confidence intervals and significance-level derived using a parametric bootstrap hypothesis test with a generalised likelihood ratio test statistic. 10 Cotton-Myer grades before and after the balloon dilatation procedure (in-hospital) were compared using Fisher's exact tests. 11 
| RE SULTS
| Cohort for analysis
A total of 65 patients were entered into the AIR database; five patients did not have any recorded information regarding the balloon dilatation intervention, and one procedure was conducted for indications other than airway stenosis (Supplementary Material 4). The remaining 59 patients had a total of 133 balloon procedures during 128 separate hospital visits, at 10 treating centres. 
| Data coverage
| Patient characteristics
Characteristics of the 59 eligible patients are summarised in 12 and nine general quality of life questionnaires were entered into the AIR.
| Procedures
Characteristics of the 133 registry procedures are summarised in Table 2 ; 31 patients had a single balloon dilatation procedure, 13 had two, five had three, five had four, and five patients had five or more required an unplanned high-dependency unit (HDU) visit without intubation and one patient with a tracheostomy was admitted to ward (rather than anticipated HDU).
| In-hospital outcomes
In-hospital complications were reported in 11 hospital visits where a balloon dilatation procedure was conducted, three of which were excluded following clinical review as they were not considered to be a complication of the procedure (Supplementary Material 9).
Of the 64 balloon dilatation visits with a tracheostomy in place, one reported an in-hospital complication (lower respiratory tract infection). Of the 64 balloon dilatation visits without a tracheostomy, seven reported complications (five airway obstruction, one emergency tracheostomy and one staged tracheostomy with prolonged intubation). The increased odds of experiencing a complication without a tracheostomy (versus with) were not significant, odds ratio 7.7
[95% CI 0.9 to 64.8] and P = .06.
| Long-term outcomes
Follow-up information from the registry (after the first recorded balloon admission) was available in 40 (68%) patients making 119 subsequent hospital visits (including 69 balloon and 50 non-balloon visits).
A total of 45 (76%) patients from the AIR were linked to HES APC.
Of these, 43 patients were readmitted a total of 500 times (median 
| Overall success
Overall procedural success rate in patients undergoing balloon dilatation as the primary treatment of stenosis (n = 52) was 65% (22% in the presence of tracheostomy, 88% in those with no tracheostomy), and 71% in those patients undergoing balloon dilatation as an adjunctive treatment subsequent to open reconstructive surgery (n = 7; Figure 3 ).
| D ISCUSS I ON
| Synopsis of key findings
The children having balloon dilatation captured in the AIR were a high-risk population: 61% were born prematurely; 51% had three or more intubations, 49% had chronic lung disease, and 12% had adjunctive treatment post-laryngotracheal reconstruction.
In terms of safety, clinically verified in-hospital complications occurred in 8/133 balloon dilatation procedures (6%). Our study suggests that the rate of complication in those without a tracheostomy exceeded the rate in those with, but our study was too small to show this conclusively. Pending further evidence, a precautionary approach would be to conduct balloon dilatation in large acute hospitals with paediatric intensive care facilities.
In terms of efficacy, our study of 59 patients demonstrates a sig- When considering overall procedural success, for patients undergoing balloon dilatation as the primary treatment of stenosis the success rate was 86% in the subgroup of patients who did not have a tracheostomy in place at the time of the balloon. This is likely due to this population having softer and lower Cotton-Myer grade stenoses. Success rates were lower in the tracheostomy group, but balloon dilatation did enable 22% to be successfully decannulated by the end of the study. However, procedural success is a crude outcome measure determined at the end of the study and may not reflect the final outcome for each child, whose pathway may extend beyond this time.
| Strengths of the study
Our study represents the largest multi-centre prospective study of balloon dilatation in treatment of laryngotracheal stenosis in the UK.
Good clinician engagement with the AIR was achieved, with a high volume of registered users and centres thus enabling collection of rich data (not routinely available from administrative data).
| Comparisons with other studies
Previously published evidence on the efficacy of balloon dilatation in the treatment of laryngotracheal stenosis in children is limited to retrospective case reviews and case reports. One systematic review, including seven case series and 150 patients, estimated the overall treatment success (avoidance of tracheostomy or laryngotracheal reconstruction) as 65% (95% CI 60 to 71%) over short-term follow-up of 7 months and mean number of 1.9 dilatation procedures per patients during that time. 8 Another systematic review determined procedural success in achieving a functional airway without open surgery or tracheostomy for balloon and rigid dilatation separately. 7 This reported an overall success rate of 50% in studies using balloon dilatation alone (six case studies, n = 10 patients) and between 50% and 78% in studies using balloon dilatation with an adjuvant therapy including CO 2 or KTP laser, topical or intra-lesional steroid (six studies, n = 24 patients).
Lastly, this systematic review calculated morbidity and mortality rates associated with dilatation of 14% and 1%, respectively; however, this combines results from both balloon and rigid dilatation.
F I G U R E 3
Overall procedural success and clinical outcomes for all balloon dilatation patients (n = 59) using follow-up from the Airway Intervention Registry and administrative data from Hospital Episodes Statistics Retrospective reviews have reported up to 33 balloon procedures in a single patient, 13 and a ten-year retrospective review in the UK found that 148/166 patients (89%) required multiple balloon procedures. 14 In our study, 56% of patients (33/59) had multiple balloon procedures to maintain the airway. Therefore, balloon dilation is one modality which should be considered as part of a series of interventions and form part of a management plan.
| Clinical applicability of the study
Short-term efficacy evidence demonstrates a significant increase in subglottic airway diameter, which is independent of pre-balloon Cotton-Myer grade, airway diameter, stenotic type and balloon procedure number. Some patients show a clear benefit in increased airway following balloon dilatation which is sustained over time;
however due to heterogeneity in patients (ie tracheostomy status, prematurity, stenotic type soft/hard and congenital cause), we did not identify particular patient characteristics that predicted benefit.
Additionally, our study did not have enough information to determine change in patient quality of life.
The long-term increases in airway diameter found in this study
were not compared with the increases expected due to natural growth; 6 however, the natural history of progression of airway stenosis is not well understood. It cannot be assumed that stenosis will progressively widen with the general growth of the child. In many cases, soft stenosis will worsen over time and result in a firmer and narrower stenotic segment. Therefore, demonstration of a significant and sustained increase in airway diameter in this complex population over time does add to the evidence base for the procedures. However, one needs to consider the high likelihood of multiple balloon procedures and the requirement for adjunctive treatments to maintain the airway.
The prospective AIR database was set up to capture safety and efficacy evidence for balloon dilatation procedures, and by conducting pseudonymised linkage to administrative data, we have been able to demonstrate both short-and long-term safety and efficacy to support the use of balloon dilatation in the treatment of subglottic stenosis.
